Next 10 |
BEIJING, March 28, 2024 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”, Nasdaq: GTH), a leading precision oncology platform company in China that specializes in offering molecular profiling tests, early cancer screening products and c...
2024-02-21 07:06:31 ET More on Genetron Holdings Genetron Holdings' Enticing Arbitrage Return Financial information for Genetron Holdings Read the full article on Seeking Alpha For further details see: Genetron Health shareholders approve merger to go pri...
BEIJING, Feb. 21, 2024 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”, NASDAQ: GTH), a leading precision oncology platform company in China that specializes in offering molecular profiling tests, early cancer screening products and co...
2024-02-05 14:00:00 ET Summary Welcome to another installment of our monthly Rare Stock Picks series. Today, we're highlighting January 2024 investment picks you may have missed. As you know, some Seeking Alpha analysts are more discerning by nature. Others are finding compelling ...
BEIJING, Jan. 17, 2024 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”, NASDAQ: GTH), a leading precision oncology platform company in China that specializes in offering molecular profiling tests, early cancer screening products and co...
2024-01-09 11:14:54 ET Summary Genetron Holdings Ltd. is a Buy with a 9.2% arbitrage return and favorable odds of timely deal closure. Concerns include geopolitical risks and the possibility of the deal stalling indefinitely. Regulatory risk exists as approval from Chinese aut...
2023-11-01 00:36:04 ET Summary Merger arbitrage spreads are wide. A number of opportunities with spreads from 10% to 137%. A review of the most interesting merger arb setups. Merger arbitrage is an event-driven investment strategy centered around betting on the succe...
2023-10-19 23:40:00 ET Summary Genetron Health has increased its revenues by more than 20% annually over three years, but profits have proved elusive. The cancer diagnostics industry, which makes most of its money from out-of-hospital screening, is grappling with high sales costs ...
2023-10-11 17:00:27 ET More on Genetron Holdings Financial information for Genetron Holdings For further details see: Genetron Holdings enters into merger agreement to go private
Advanced Health Intelligence Ltd ADS (AHI) is expected to report for quarter end 2023-06-30 Home Bistro Inc (HBIS) is expected to report for quarter end 2023-07-31 Karooooo Ltd. (KARO) is expected to report $0.29 for Q2 2024 Winmark Corporation (WINA) is expected to report for Q4 2023...
News, Short Squeeze, Breakout and More Instantly...
Genetron Holdings Limited Company Name:
GTH Stock Symbol:
NASDAQ Market:
BEIJING, March 28, 2024 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (("Genetron Health" or the "Company", NASDAQ:GTH), a leading precision onc...
BEIJING, March 28, 2024 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”, Nasdaq: GTH), a leading precision oncology platform company in China that specializes in offering molecular profiling tests, early cancer screening products and c...
BEIJING, Feb. 21, 2024 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (("Genetron Health" or the "Company", NASDAQ:GTH), a leading precision onco...